HomeCHM • ASX
add
Chimeric Therapeutics Ltd
Previous close
$0.014
Year range
$0.013 - $0.047
Market cap
19.46M AUD
Avg Volume
1.08M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | -1.76M | -348.85% |
Operating expense | 5.28M | -28.45% |
Net income | -7.49M | -5.68% |
Net profit margin | 426.27 | 142.47% |
Earnings per share | — | — |
EBITDA | -6.77M | -5.43% |
Effective tax rate | -0.55% | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.05M | -43.14% |
Total assets | 15.27M | -31.74% |
Total liabilities | 12.80M | -23.40% |
Total equity | 2.47M | — |
Shares outstanding | 876.06M | — |
Price to book | ∞ | — |
Return on assets | -115.10% | — |
Return on capital | -711.67% | — |
Cash Flow
Net change in cash
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -7.49M | -5.68% |
Cash from operations | -1.43M | 21.26% |
Cash from investing | -11.72K | 81.66% |
Cash from financing | 1.19M | -4.10% |
Net change in cash | -236.20K | 62.61% |
Free cash flow | -4.17M | -17.06% |
About
Founded
2020
Website